This paper examines an early attempt to purge the medical field of commercial exploitation and promote rational therapeutics. The historical study of the origin of the double-blind randomized controlled trial as a standard of therapeutic efficacy reveals that concerns which seem entirely modern, are actually deeply entrenched in the history of medical research. Specifically, those whose primary concern was with ending the use of inefficacious, and sometimes positively dangerous drugs, found themselves in an ideological battle with those who benefitted financially from their use.
|Title of host publication||Boston Studies in the Philosophy and History of Science|
|Number of pages||20|
|Publication status||Published - 2020|
|Name||Boston Studies in the Philosophy and History of Science|
Bibliographical notePublisher Copyright:
© 2020, Springer Nature Switzerland AG.
All Science Journal Classification (ASJC) codes
- Social Sciences (miscellaneous)
- Literature and Literary Theory
- History and Philosophy of Science